Ojaimi C, Qanud K, Hintze TH, Recchia FA. Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. Physiol Genomics 29: 76 -83, 2007. First published December 12, 2006; doi:10.1152/physiolgenomics.00159.2006.-Our aim was to determine the changes in the gene expression profile occurring during the transition from compensated dysfunction (CD) to decompensated heart failure (HF) in pacing-induced dilated cardiomyopathy. Twelve chronically instrumented dogs underwent left ventricular pacing at 210 beats/min for 3 wk and at 240 beats thereafter, and four normal dogs were used as control. The transition from CD to HF occurred between the 3rd and 4th wk of pacing, with end-stage HF at 28 Ϯ 1 days. RNA was extracted from left ventricular tissue at control and 3 and 4 wk of pacing (n ϭ 4) and tested with the Affymetrix Canine Array. We found 509 genes differentially expressed in CD vs. control (P Յ 0.05, fold change ՆϮ2), with 362 increasing and 147 decreasing; 526 genes were differentially expressed in HF vs. control (P Յ 0.05; fold change ՆϮ2), with 439 increasing and 87 decreasing. To better understand the transition, we compared gene alterations at 3 vs. 4 wk pacing and found that only 30 genes differed (P Յ 0.05; fold change of Ϯ2). We conclude that a number of processes including normalization of gene regulation during decompensation, appearance of new upregulated genes and maintenance of gene expression all contribute to the transition to overt heart failure with an unexpectedly small number of genes differentially regulated. heart failure; pacing dog; microarray OVER THE PAST YEARS OTHER authors and we have used chronically instrumented dogs with high-frequency cardiac pacing to study pathophysiological and molecular mechanisms related to the development of dilated cardiomyopathy. This model of congestive heart failure is characterized by a very predictable evolution and reproduces many key features of the human disease, including progressive ventricular chambers dilation and wall thinning, decreased contractility, neurohormonal activation, beta adrenergic desensitization, and altered metabolism (19). In particular, we could determine functional and metabolic changes occurring only between the 3rd and 4th wk of pacing, i.e., during the transition from compensated to decompensated failure (25). The marked cardiac functional impairment and systemic deterioration observed during this relatively short phase of transition suggests the occurrence of profound molecular alterations. Their identification would provide notable insights in the pathophysiology and clinical management of heart failure. Unfortunately, given the complexity of the heart failure syndrome, such molecular changes are likely very numerous and interrelated, while most studies have been focused on single or selected groups of molecules, due to the limitations of the classical methods of analysis.More recently, global gene transcript profiling has emerged as a powerful tool f...